Torthaí cuardaigh - Rob C. Roovers
- 1 - 20 toradh as 20 á dtaispeáint
-
1
Structural Evaluation of EGFR Inhibition Mechanisms for Nanobodies/VHH Domains de réir Karl R. Schmitz, Atrish Bagchi, Rob C. Roovers, Paul M.P. van Bergen en Henegouwen, Kathryn M. Ferguson
Foilsithe / Cruthaithe 2013Artigo -
2
-
3
EGFR endocytosis requires its kinase activity and N-terminal transmembrane dimerization motif de réir Raimond Heukers, Jeroen F. Vermeulen, Farzad Fereidouni, Arjen N. Bader, Jarno Voortman, Rob C. Roovers, Hans C. Gerritsen, Paul M.P. van Bergen en Henegouwen
Foilsithe / Cruthaithe 2013Artigo -
4
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies de réir Rob C. Roovers, Toon Laeremans, Lieven Huang, Severine De Taeye, Arie J. Verkleij, Hilde Revets, Hans J. de Haard, Paul M.P. van Bergen en Henegouwen
Foilsithe / Cruthaithe 2006Artigo -
5
A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies de réir Hans J. de Haard, Nicole van Neer, Anneke W. Reurs, Simon E. Hufton, Rob C. Roovers, Paula Henderikx, Adriaan P. de Bruı̈ne, Jan‐Willem Arends, Hennie R. Hoogenboom
Foilsithe / Cruthaithe 1999Artigo -
6
Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy de réir Mans Broekgaarden, Remko van Vught, Sabrina Oliveira, Rob C. Roovers, Paul M.P. van Bergen en Henegouwen, Roland J. Pieters, T.M. van Gulik, Eefjan Breukink, Michal Heger
Foilsithe / Cruthaithe 2016Artigo -
7
EGF induces coalescence of different lipid rafts de réir Erik Hofman, Mika O. Ruonala, Arjen N. Bader, Dave van den Heuvel, Jarno Voortman, Rob C. Roovers, Arie J. Verkleij, Hans C. Gerritsen, Paul M.P. van Bergen en Henegouwen
Foilsithe / Cruthaithe 2008Artigo -
8
Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform de réir A. Klarenbeek, Khalil El Mazouari, Aline Desmyter, Christophe Blanchetot, Anna Hultberg, Natalie De Jonge, Rob C. Roovers, Christian Cambillau, S. Spinelli, Jurgen Del‐Favero, Theo Verrips, Hans J. de Haard, Ikbel Achour
Foilsithe / Cruthaithe 2015Artigo -
9
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET de réir Maria J.W.D. Vosjan, Lars R. Perk, Rob C. Roovers, Gerard W.M. Visser, Marijke Stigter‐van Walsum, Paul M.P. van Bergen en Henegouwen, Guus A.M.S. van Dongen
Foilsithe / Cruthaithe 2011Artigo -
10
Therapeutic stem cells expressing variants of EGFR-specific nanobodies have antitumor effects de réir Jeroen A. J. M. van de Water, Tugba Bagcı-Önder, Aayush S Agarwal, Hiroaki Wakimoto, Rob C. Roovers, Yanni Zhu, Randa Kasmieh, Deepak Bhere, Paul M.P. van Bergen en Henegouwen, Khalid Shah
Foilsithe / Cruthaithe 2012Artigo -
11
Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles de réir Raimond Heukers, Işıl Altıntaş, Smiriti Raghoenath, Erica De Zan, Richard A. Pepermans, Rob C. Roovers, Rob Haselberg, Wim E. Hennink, Raymond M. Schiffelers, Robbert J. Kok, Paul M.P. van Bergen en Henegouwen
Foilsithe / Cruthaithe 2013Artigo -
12
Rapid Visualization of Human Tumor Xenografts through Optical Imaging with a Near-Infrared Fluorescent Anti–Epidermal Growth Factor Receptor Nanobody de réir Sabrina Oliveira, Guus A.M.S. van Dongen, Marijke Stigter‐van Walsum, Rob C. Roovers, Jord C. Stam, Willem P.Th.M. Mali, P. J. van Diest, Paul M.P. van Bergen en Henegouwen
Foilsithe / Cruthaithe 2012Artigo -
13
Amphiregulin Enhances Regulatory T Cell-Suppressive Function via the Epidermal Growth Factor Receptor de réir Dietmar M. Zaiss, Jorg van Loosdregt, Andrea Gorlani, Cornelis P. J. Bekker, Andrea Gröne, Maria Sibilia, Paul M.P. van Bergen en Henegouwen, Rob C. Roovers, Paul J. Coffer, Alice J.A.M. Sijts
Foilsithe / Cruthaithe 2013Artigo -
14
A biparatopic anti‐EGFR nanobody efficiently inhibits solid tumour growth de réir Rob C. Roovers, Maria J.W.D. Vosjan, Toon Laeremans, Rachid el Khoulati, Renée C.G. de Bruin, Kathryn M. Ferguson, Arie J. Verkleij, Guus A.M.S. van Dongen, Paul M.P. van Bergen en Henegouwen
Foilsithe / Cruthaithe 2011Artigo -
15
MCLA-117, a CLEC12AxCD3 bispecific antibody targeting a leukaemic stem cell antigen, induces T cell-mediated AML blast lysis de réir Pieter Fokko van Loo, Basav N. Hangalapura, Soley Thordardottir, John D. Gibbins, Henrike Veninga, Linda Hendriks, Arjen Kramer, Rob C. Roovers, Marij Leenders, John de Kruif, Robert P. Doornbos, Andres Sirulnik, Mark Throsby, Ton Logtenberg, Harry Dolstra, Alexander B. H. Bakker
Foilsithe / Cruthaithe 2019Artigo -
16
A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies de réir Roeland Lameris, Jurjen M. Ruben, Victoria Iglesias‐Guimarais, Milon de Jong, Myrthe Veth, Fleur S. van de Bovenkamp, Iris de Weerdt, Arnon P. Kater, Sonja Zweegman, Sjeng Horbach, Thilo Riedl, Benjamin Winograd, Rob C. Roovers, Anton E.P. Adang, Tanja D. de Gruijl, Paul W.H.I. Parren, Hans van Vliet
Foilsithe / Cruthaithe 2023Artigo -
17
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors de réir Lisa A. King, Elisa C. Toffoli, Myrthe Veth, Victoria Iglesias‐Guimarais, Manon C. Slot, Derk Amsen, Rieneke van de Ven, Sarah Derks, Marieke F. Fransen, Jurriaan B. Tuynman, Thilo Riedl, Rob C. Roovers, Anton E.P. Adang, Jurjen M. Ruben, Paul W.H.I. Parren, Tanja D. de Gruijl, Hans van Vliet
Foilsithe / Cruthaithe 2023Artigo -
18
A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells de réir Renée C.G. de Bruin, John P. Veluchamy, Sinéad M. Lougheed, Famke L. Schneiders, Silvia Lopez‐Lastra, Roeland Lameris, Anita G.M. Stam, Zsolt Sebestyén, Jürgen Kuball, Carla F.M. Molthoff, Erik Hooijberg, Rob C. Roovers, James P. Di Santo, Paul M.P. van Bergen en Henegouwen, Henk M.W. Verheul, Tanja D. de Gruijl, Hans van Vliet
Foilsithe / Cruthaithe 2017Artigo -
19
The architecture of EGFR’s basal complexes reveals autoinhibition mechanisms in dimers and oligomers de réir Laura C. Zanetti-Domingues, Dimitris Korovesis, Sarah R. Needham, Christopher J. Tynan, Shiori Sagawa, Selene K. Roberts, Antonija Kuzmanic, Elena Ortiz‐Zapater, Purvi Jain, Rob C. Roovers, Alireza Lajevardipour, Paul M.P. van Bergen en Henegouwen, George Santis, Andrew H. A. Clayton, David T. Clarke, Francesco Luigi Gervasio, Yibing Shan, David E. Shaw, Daniel J. Rolfe, Peter J. Parker, Marisa L. Martin-Fernandez
Foilsithe / Cruthaithe 2018Artigo -
20
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors de réir Bram Herpers, Berina Eppink, Mark I. James, Carme Cortina, Adrià Cañellas‐Socias, Sylvia F. Boj, Xavier Hernando‐Momblona, Dominik Głodzik, Rob C. Roovers, Marc van de Wetering, Carina Bartelink-Clements, Vanessa Zondag-van der Zande, Jara García Mateos, Kuan Yan, Lucia Salinaro, Abdul Basmeleh, Szabolcs Fátrai, David Maussang, Jeroen J. Lammerts van Bueren, Irene Chicote, Garazi Serna, Laia Cabellos, Lorena Ramírez, Paolo Nucíforo, Ramón Salazar, Cristina Santos, Alberto Villanueva, Camille Stephan‐Otto Attolini, Elena Sancho, Héctor G. Pálmer, Josep Tabernero, Michael R. Stratton, John de Kruif, Ton Logtenberg, Hans Clevers, Leo Price, Robert G.J. Vries, Eduard Batlle, Mark Throsby
Foilsithe / Cruthaithe 2022Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Biochemistry
Cancer research
Receptor
Immunology
Cell biology
Chemistry
Antibody
Epidermal growth factor receptor
Medicine
Epidermal growth factor
Gene
Genetics
Organic chemistry
Signal transduction
Cancer
Immune system
In vivo
Receptor tyrosine kinase
T cell
Tyrosine kinase
Biophysics
Biotechnology
Cetuximab
In vitro
Internal medicine
Ligand (biochemistry)
Stem cell
Antigen
CD3